Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Financial Disclosure

The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Barry Byrne

University of Florida, Department: Md Cognital Hrt Ctr Excellence

Should you be removed from our database? Contact us at [email protected]. Read more below.

AAVANTI

Listed Reason

The proposed external activity to manage a U41 grant proposal which will facilitate a phase II STTR related to future clinical studies in Freidreich's ataxia. No activity other than project management will be conducted at AVANTI. The company is not a licensee of any UF technology.

Additional Comments

Off campus.

Filed on February 02, 2017.

Tell us what you know about Barry Byrne's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Barry Byrne University of Florida Financial Disclosure Sarepta
Barry Byrne University of Florida Financial Disclosure Pfizer
Barry Byrne University of Florida Financial Disclosure 4D Molecular Therapeutics
Barry Byrne University of Florida Financial Disclosure Sanofi
Barry Byrne University of Florida Financial Disclosure Lacerta Therapeutics
Barry Byrne University of Florida Financial Disclosure Pfizer
Barry Byrne University of Florida Financial Disclosure Sarepta
Barry Byrne University of Florida Financial Disclosure Applied Genetic Technologies Corporation
Barry Byrne University of Florida Financial Disclosure Genzyme Corporation (Biomarin-Genzyme)
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page